ORBIMED
OrbiMed is a healthcare-dedicated investment firm, with approximately $5 billion in assets under management. OrbiMed's investment advisory business was founded in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies. OrbiMed manages the Caduceus Private Investments series of venture capital funds and a family of public equity investment funds.
ORBIMED
Industry:
Angel Investment Financial Services Health Care
Founded:
1989-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Domain Not Resolving Global Site Tag IPv6 Pound Sterling
Similar Organizations
Cain Brothers
Cain Brothers is a healthcare-focused investment firm offering advice on mergers and acquisitions.
Frazier Healthcare Partners
Frazier Healthcare Partners is a healthcare investment firm for pharmaceuticals, healthcare services, & medical products.
Future Fund
Future Fund is an investment fund connected to the Australian Government.
Indian Angel Network
Indian Angel Network is one of the leading Angel Investors Network in India. We are the business angel or informal investor.
MassMutual Ventures
MMV is a multi-stage, global venture capital firm investing in enterprise software, cybersecurity, financial technology, and digital health.
Musha Ventures
Musha Ventures is an Africa-focused micro VC and angel fund.
New Enterprise Associates
New Enterprise Associates is a global venture capital firm investing in technology and healthcare.
RA Capital Management
RA Capital Management is an investment advisor specializing in the life-sciences and drug development sectors.
Soesbe Financial
Soesbe Financial is a financial planning firm.
Starta VC
Starta is a venture ecosystem to find, foster and fund early stage talent in tech. We help startups gain traction in USA and scale globally.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-06-17 | Response Biomedical | Response Biomedical acquired by OrbiMed | 11 M USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-10 | Disc Medicine | OrbiMed investment in Venture Round - Disc Medicine | N/A |
| 2022-07-18 | Delfi Diagnostics | OrbiMed investment in Series B - Delfi Diagnostics | 225 M USD |
| 2022-07-11 | LifeWell | OrbiMed investment in Venture Round - LifeWell | 80 M USD |
| 2022-06-30 | X4 Pharmaceuticals | OrbiMed investment in Post-IPO Equity - X4 Pharmaceuticals | 55 M USD |
| 2022-06-29 | MiroBio | OrbiMed investment in Series B - MiroBio | 80 M GBP |
| 2022-06-24 | Frontera Therapeutics | OrbiMed investment in Series B - Frontera Therapeutics | 160 M USD |
| 2022-06-16 | Aerin Medical | OrbiMed investment in Private Equity Round - Aerin Medical | 60 M USD |
| 2022-06-09 | DarioHealth | OrbiMed investment in Post-IPO Debt - DarioHealth | 50 M USD |
| 2022-06-09 | CHARM Therapeutics | OrbiMed investment in Series A - CHARM Therapeutics | 50 M USD |
| 2022-06-02 | Upstream Bio | OrbiMed investment in Series A - Upstream Bio | 200 M USD |
Newest Events participated
More informations about "OrbiMed"
About - OrbiMed
OrbiMed is typically a lead investor, helping to build our portfolio companies into market leaders. We invest globally, including across North America, Asia, and Europe. Private Credit/Royalty. OrbiMed provides commercial-stage …See details»
OrbiMed - Wikipedia
OrbiMed (OrbiMed Advisors) is an American investment firm based in New York City, United States. It is focused on making public and private investments in the Healthcare and Biotechnology industries. OrbiMed is considered one of the world's largest dedicated healthcare investment firms. See details»
Leadership – OrbiMed
OrbiMed's team includes over 130 experienced professionals with expertise in the life sciences industry, medicine, science, and finance. We foster significant collaboration between our public and private equity and credit teams, through …See details»
OrbiMed - Crunchbase Investor Profile & Investments
OrbiMed is a healthcare-dedicated investment firm, with approximately $5 billion in assets under management. OrbiMed's investment advisory business was founded in 1989 with a vision to invest across the spectrum of healthcare …See details»
Know Your Investor: OrbiMed Advisors
Nov 2, 2023 Know Your Investor’s October Edition focuses on a renowned healthcare investment firm, OrbiMed Advisors, known for making considerable investments in healthcare companies . In 1989, Viren Mehta and Samuel Isaly …See details»
OrbiMed Raises $4.3 Billion Across Private Investment …
Oct 24, 2023 About OrbiMed OrbiMed is a leading healthcare investment firm with more than $17 billion in assets under management. OrbiMed invests globally across the healthcare industry, from start-ups to ...See details»
OrbiMed - Investments, Portfolio & Company Exits - Crunchbase
OrbiMed has acquired Response Biomedical on Jun 17, 2016. They acquired Response Biomedical for $11M. Unlock for free . Investments. Number of Investments 690. Number of …See details»
Gunderson Dettmer Advises OrbiMed in closing more …
Oct 24, 2023 Gunderson Dettmer represented client OrbiMed, a global healthcare investment firm, in closing more than $4.3 billion in capital commitments for its latest private investment funds. The new capital was …See details»
OrbiMed raises $4.3bn for latest biotech funds
1 day ago International healthcare investment group OrbiMed has raised around $4.3 billion in committed financing for distribution across three new private funds that will be used to support life sciences ...See details»
Portfolio - OrbiMed
Referenced companies reflect current portfolio holdings of OrbiMed-managed private equity funds. There is no assurance that any securities discussed herein are, or will remain, in an OrbiMed-managed portfolio. Any such securities do …See details»
M&A, drug discovery hype propel OrbiMed’s $4.3B healthcare …
Oct 24, 2023 OrbiMed has closed on more than $4 billion in fresh commitments across three funds, riding momentum from a strong year of acquisitions in the pharmaceutical and biotech …See details»
OrbiMed nets $4.5B across 3 funds - Fierce Biotech
Oct 24, 2023 | OrbiMed, one of the biggest global financers of private and public biopharmas, has brought in $4.3 billion to shower on new startups in the coming years. OrbiMed nets $4.5B …See details»
Led by OrbiMed, HiRO Raised Tens of Millions of US Dollars
Mar 17, 2022 This round of investment is led by OrbiMed, with the participation from existing shareholder, Fontus Capital. Shanghai, March 18th, 2022 - Harvest Integrated Research …See details»
OrbiMed - VentureRadar
OrbiMed invests across the entire spectrum of pharmaceutical, biotechnology and medical device companies on a worldwide basis. Investments are made through private equity funds, hedge …See details»
ADB, OrbiMed Sign $75 Million Deal to Enhance Health Care …
MANILA, PHILIPPINES (7 January 2021) — The Asian Development Bank (ADB) signed a $75 million equity investment in OrbiMed Asia Partners IV, LP (OAP IV), a private equity fund …See details»
OrbiMed - Funding, Financials, Valuation & Investors - Crunchbase
OrbiMed has raised a total of $8.6B across 17 funds, their latest being OrbiMed Private Investments IX. Announced Date . Fund Name . Money Raised . Oct 24, 2023: OrbiMed …See details»
Bob Smith – OrbiMed
Bob joined OrbiMed in 2024 as a Venture Partner. He brings over thirty years of experience in alliance management, business development, commercial, mergers and acquisitions, and …See details»
List of top OrbiMed Portfolio Companies - Crunchbase
Jan 4, 2010 OrbiMed is a healthcare-dedicated investment firm focusing on biopharmaceuticals for medical devices and diagnostics. This list of organizations invested in by OrbiMed provides …See details»
Led by OrbiMed, HiRO Raised Tens of Millions of US Dollars in …
SHANGHAI, March 17, 2022 /PRNewswire/ -- Harvest Integrated Research Organization ("HiRO" or the "Company") announced the completion of its Series A financing in the tens of millions of …See details»